Live Chart

O 0

H 0

L 0

VOL 0

Transgene Biotek Overview

Days Range

Low: ₹4.11
High: ₹4.35
Previous Close ₹4.32
Open ₹4.35
Volume 82,198
Day’s Range ₹4.11 - ₹4.35
52W Range ₹2.28 - ₹5.09
Market Cap ₹32.73 Cr

Fundamentals of Transgene Biotek

ROCE (TTM) -23.47%
P/E Ratio (TTM) NA
P/B Ratio 2.88
Industry P/E 57.63
Debt to Equity 1.15
ROE -52.85%
EPS (TTM) NA
Dividend Yield NA
Book Value 2
Face Value 10

Financials of Transgene Biotek

Sep 2022Dec 2022Mar 2023Jun 2023
Net Sales0000.1
Expenses1.771.381.470.25
Profit before tax-1.77-1.38-1.47-0.14
Operating Profit-1.77-1.38-1.47-0.14
Net Profit-1.77-1.38-1.47-0.14
EPS in Rs-0.23-0.18-0.19-0.02

About Transgene Biotek

Transgene Biotek was incorporated as a private limited company in Mar.'90 and was converted into a public limited company in Nov.'90. The company is engaged in the research and development and manu ... Read More

Parent Organisation Indian Private
Founded 1990
Managing Director K Koteswara Rao
NSE Symbol NA

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Aster DM Healthcare Ltd ₹16,304.11

325.85

0.55 (-0.17%)

321.8 - 330.1
Opto Circuits (India) Ltd ₹53.51

1.8

0.00 (0.00)

1.8 - 1.85
Indraprastha Medical Corporation Ltd ₹1,467.18

159.65

1.20 (-0.75%)

157.55 - 161.5
Krsnaa Diagnostics Ltd ₹2,037.39

652.6

3.95 (0.61%)

643.3 - 667.9
Vijaya Diagnostic Centre Ltd ₹4,875.09

465.65

11.35 (-2.38%)

463.35 - 484.25

What's Trending

FAQs

What is the Share price of Transgene Biotek ()?

Transgene Biotek () share price as of September 21, 2023, on BSE is Rs 4.25 (BSE).

Can I buy Transgene Biotek () shares?

Yes, You can buy Transgene Biotek () shares by opening a Demat account with Angel One.

How do I buy Transgene Biotek () from Angel One?

Transgene Biotek () share can be brought through the following modes:
  1. Direct investment: You can buy Transgene Biotek () shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Transgene Biotek () shares.